Jasper Hellweg
Stock Analyst at Argus Research
(3.78)
# 813
Out of 4,479 analysts
55
Total ratings
53.73%
Success rate
6.51%
Average return
Main Sectors:
24 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,060 → $1,170 | $1,057.02 | +10.69% | 5 | Jun 25, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $465 → $550 | $471.25 | +16.71% | 4 | Jun 17, 2024 | |
| AZN AstraZeneca | Maintains: Buy | $80 → $85 | $77.94 | +9.06% | 3 | May 30, 2024 | |
| NVO Novo Nordisk | Maintains: Buy | $115 → $125 | $145.42 | -14.04% | 1 | Feb 1, 2024 | |
| MRNA Moderna | Maintains: Buy | $160 → $140 | $115.95 | +20.74% | 4 | Sep 13, 2023 | |
| MDRX Veradigm | Downgrades: Hold | n/a | $9.50 | - | 2 | Jul 6, 2023 | |
| BIIB Biogen | Maintains: Buy | $320 → $350 | $231.77 | +51.01% | 3 | May 11, 2023 | |
| UTHR United Therapeutics | Maintains: Buy | $300 → $280 | $319.01 | -12.23% | 3 | Apr 21, 2023 | |
| ABBV AbbVie | Downgrades: Hold | n/a | $170.37 | - | 2 | Apr 5, 2023 | |
| SNY Sanofi | Maintains: Buy | $55 → $60 | $49.59 | +20.99% | 1 | Mar 27, 2023 | |
| ILMN Illumina | Downgrades: Hold | n/a | $105.50 | - | 3 | Jan 25, 2023 | |
| ZTS Zoetis | Maintains: Buy | $225 → $200 | $172.58 | +15.89% | 3 | Jun 17, 2022 | |
| TEVA Teva Pharmaceutical | Downgrades: Hold | n/a | $16.34 | - | 1 | Jan 27, 2022 | |
| IQV IQVIA Holdings | Maintains: Buy | n/a | $208.49 | - | 4 | Sep 10, 2021 | |
| ITGR Integer Holdings | Upgrades: Buy | n/a | $115.16 | - | 1 | Jun 9, 2021 | |
| LH Labcorp Holdings | Maintains: Buy | n/a | $203.13 | - | 3 | May 20, 2021 | |
| EBS Emergent BioSolutions | Downgrades: Hold | n/a | $7.06 | - | 1 | May 5, 2021 | |
| DGX Quest Diagnostics | Upgrades: Buy | n/a | $137.09 | - | 1 | Oct 21, 2020 | |
| BAX Baxter International | Downgrades: Hold | n/a | $33.06 | - | 1 | Sep 4, 2020 | |
| PRGO Perrigo Company | Downgrades: Hold | n/a | $26.25 | - | 1 | Apr 17, 2020 | |
| EFX Equifax | Downgrades: Hold | n/a | $236.42 | - | 3 | Apr 6, 2020 | |
| LGND Ligand Pharmaceuticals | Downgrades: Hold | n/a | $84.85 | - | 1 | Mar 24, 2020 | |
| HCA HCA Healthcare | Maintains: Buy | n/a | $315.12 | - | 2 | Nov 6, 2018 | |
| MAN ManpowerGroup | Maintains: Buy | n/a | $69.44 | - | 2 | Oct 22, 2018 |
Regeneron Pharmaceuticals
Jun 25, 2024
Maintains: Buy
Price Target: $1,060 → $1,170
Current: $1,057.02
Upside: +10.69%
Vertex Pharmaceuticals
Jun 17, 2024
Maintains: Buy
Price Target: $465 → $550
Current: $471.25
Upside: +16.71%
AstraZeneca
May 30, 2024
Maintains: Buy
Price Target: $80 → $85
Current: $77.94
Upside: +9.06%
Novo Nordisk
Feb 1, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $145.42
Upside: -14.04%
Moderna
Sep 13, 2023
Maintains: Buy
Price Target: $160 → $140
Current: $115.95
Upside: +20.74%
Veradigm
Jul 6, 2023
Downgrades: Hold
Price Target: n/a
Current: $9.50
Upside: -
Biogen
May 11, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $231.77
Upside: +51.01%
United Therapeutics
Apr 21, 2023
Maintains: Buy
Price Target: $300 → $280
Current: $319.01
Upside: -12.23%
AbbVie
Apr 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $170.37
Upside: -
Sanofi
Mar 27, 2023
Maintains: Buy
Price Target: $55 → $60
Current: $49.59
Upside: +20.99%
Illumina
Jan 25, 2023
Downgrades: Hold
Price Target: n/a
Current: $105.50
Upside: -
Zoetis
Jun 17, 2022
Maintains: Buy
Price Target: $225 → $200
Current: $172.58
Upside: +15.89%
Teva Pharmaceutical
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $16.34
Upside: -
IQVIA Holdings
Sep 10, 2021
Maintains: Buy
Price Target: n/a
Current: $208.49
Upside: -
Integer Holdings
Jun 9, 2021
Upgrades: Buy
Price Target: n/a
Current: $115.16
Upside: -
Labcorp Holdings
May 20, 2021
Maintains: Buy
Price Target: n/a
Current: $203.13
Upside: -
Emergent BioSolutions
May 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $7.06
Upside: -
Quest Diagnostics
Oct 21, 2020
Upgrades: Buy
Price Target: n/a
Current: $137.09
Upside: -
Baxter International
Sep 4, 2020
Downgrades: Hold
Price Target: n/a
Current: $33.06
Upside: -
Perrigo Company
Apr 17, 2020
Downgrades: Hold
Price Target: n/a
Current: $26.25
Upside: -
Equifax
Apr 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $236.42
Upside: -
Ligand Pharmaceuticals
Mar 24, 2020
Downgrades: Hold
Price Target: n/a
Current: $84.85
Upside: -
HCA Healthcare
Nov 6, 2018
Maintains: Buy
Price Target: n/a
Current: $315.12
Upside: -
ManpowerGroup
Oct 22, 2018
Maintains: Buy
Price Target: n/a
Current: $69.44
Upside: -